Reduced chemo dose hurts chances for cure in non-Hodgkin's patients

09/21/2004 | USA Today

Patients often avoid the chemotherapy recommended for aggressive, but possibly curable, non-Hodgkin's lymphoma because of severe side effects, thereby hurting their chances of a successful outcome, a study reveals. One of the major side effects that prompted the dose reduction was a drop in the number of white blood cells, which leaves cancer patients open to infections.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA